MONCYTE Health has been selected to join a 4-year Horizon funded project as a core industrial partner, aiming to develop earlier diagnosis and co-management strategies for familial hypercholesterolemia. The project will work together with leading institutions to enable new strategies for earlier diagnosis and co-management of familial hypercholesterolemia (FH).
Company Information
Company
MONCYTE Health
Location
Helsinki, Uusimaa, Finland
About
MONCYTE Health is a diagnostics company developing patented technology aimed at optimizing the treatment and prevention of cardiovascular diseases. Their unique technology quantifies individual differences in cellular fat metabolism that contribute to high cholesterol levels and the effectiveness of lipid medications. This innovation enables tailored treatment strategies and risk assessments for patients suffering from cholesterol-related issues. The company’s mission is to accelerate improvements in patients' cholesterol levels and reduce cardiovascular disease risks.
HelsinkiBiotechnologyHealth CareMedicalTherapeuticsHealth Diagnostics